U-Chart Analysis:Carna Biosciences,Inc.:4572

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Carna Biosciences,Inc. Go to web site 4572 Medicals 東証グロース December 1, 2000 2008.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Carna Biosciences,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Carna Biosciences,Inc. Balance Sheet 2024年12月期 Carna Biosciences,Inc. Balance Sheet 2023年12月期 Carna Biosciences,Inc. Balance Sheet 2022年12月期 Carna Biosciences,Inc. Balance Sheet 2021年12月期 Carna Biosciences,Inc. Balance Sheet 2020年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents 2,108 2,889 3,379 3,818 4,299
Other Current AssetsHelp 629 1,302 725 1,501 409
Tangible Fixed AssetsHelp - 105 100 52 53
Intangible Fixed AssetHelp 0 1 2 3 4
Investments and OthersHelp 34 52 60 60 70
Total AssetsHelp 2,772 4,350 4,266 5,433 4,835
Total Current LiabilitiesHelp 264 416 476 817 771
Total Long-term LiabilitiesHelp 33 56 148 300 240
Shareholder's EquityHelp 2,475 3,878 3,642 4,316 3,824
Total LiabilitiesHelp 2,772 4,350 4,266 5,433 4,835

Carna Biosciences,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Carna Biosciences,Inc. Profit and Loss Account 2024年12月期 Carna Biosciences,Inc. Profit and Loss Account 2023年12月期 Carna Biosciences,Inc. Profit and Loss Account 2022年12月期 Carna Biosciences,Inc. Profit and Loss Account 2021年12月期 Carna Biosciences,Inc. Profit and Loss Account 2020年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales 636 1,626 1,387 2,018 1,133
Total Sales 636 1,626 1,387 2,018 1,133
Cost of SalesHelp 171 175 172 135 192
Other Costs and RevenueHelp 2,644 2,603 2,565 2,417 2,052
Total CostsHelp 2,815 2,779 2,736 2,552 2,244
Net RevenueHelp 466 1,451 1,215 1,882 941
Earnings Before TaxHelp -2,174 -1,131 -1,323 -532 -1,102
Net IncomeHelp -2,179 -1,153 -1,350 -534 -1,111
Net Income -2,179 -1,153 -1,350 -534 -1,111

Carna Biosciences,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Carna Biosciences,Inc. Cash Flow Statement 2024年12月期 Carna Biosciences,Inc. Cash Flow Statement 2023年12月期 Carna Biosciences,Inc. Cash Flow Statement 2022年12月期 Carna Biosciences,Inc. Cash Flow Statement 2021年12月期 Carna Biosciences,Inc. Cash Flow Statement 2020年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help -1,375 -1,677 -708 -1,537 -1,261
Investing Cash Flow(ICF)Help -13 -11 -126 -42 -70
Financing Cash FlowHelp 567 1,182 367 1,065 724
Exchange Difference of Cash and Cash EquivalentsHelp 40 17 28 32 -9
Net Increase and Decrease in Cash and Cash Equivalentsn -781 -490 -439 -481 -616

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Carna Biosciences,Inc.
TOMATO BANK, LTD.
JSP Corporation
KYOSHA CO.,LTD.
Inabata & Co.,Ltd.

Company where related level is highHelp

CHUKYOIYAKUHIN CO.,LTD.
Eisai Co.,Ltd.
Immuno-Biological Laboratories Co., Ltd.
Nichi-Iko Pharmaceutical Co.,Ltd.
MediciNova,Inc
MIKASA SEIYAKU CO.,LTD.
Takeda Pharmaceutical Company Limited
TSUMURA & CO.
D.Western Therapeutics Institute, Inc.
Cuorips Inc.